Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that it has successfully closed its previously announced non-brokered private placement offering (the "Offering") of units (the "Units") to establish a revolving purchase order ("PO") financing source for its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"). The Company has issued a total
Technology, Biotechnology, Health
2026-05-21 6:00 AM EDT | Restart Life Sciences Corp.
Promino Announces Closing of Third Tranche of Private Placement
Burlington, Ontario--(Newsfile Corp. - May 20, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a performance nutrition company focused on clinically validated amino acid formulations, is pleased to announce that, further to its press releases dated March 13, April 22, May 5 and May 15, 2026, the Company has closed a third tranche (the "Third Tranche") of its private placement, issuing an aggregate of 10,206,66
Food / Beverages, Sports, Health
2026-05-20 8:07 PM EDT | Promino Nutritional Sciences, Inc.
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.
Healthcare and Hospitals, Health
2026-05-20 11:58 AM EDT | Adia Nutrition Inc.
Orange Auto Insurance, Inc., Subsidiary of HPN Holdings, Inc. Appoints William Raniere as Executive Vice President of Claims & General Counsel
Chicago, Illinois--(Newsfile Corp. - May 20, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or the "Company") today announced that its subsidiary, Orange Auto Insurance, Inc ("Orange"), a technology-driven non-standard automobile insurance managing general agency, has appointed William Raniere as Executive Vice President of Claims & General Counsel. Mr. Raniere joins Orange with decades of leadership experience across the automobile insurance, claims, litigation, and legal industri
2026-05-20 9:00 AM EDT | HPN Holdings, Inc.
Sym Sciences Awarded $50,000 Grant to Advance IND-Ready Cannabinoid Research Platform
New York, New York--(Newsfile Corp. - May 20, 2026) - Sym Sciences announced today that it has been awarded a $50,000 grant from the to support the development of standardized, IND-ready cannabinoid materials for clinical research. The funding will enable Sym Sciences to expand its university research network and accelerate the preparation of regulatory-grade cannabinoid formulations designed for NIH-funded studies. The initiative is focused on streamlining the pathway from product deve
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-20 8:25 AM EDT | Sym Sciences
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
Vancouver, British Columbia--(Newsfile Corp. - May 20, 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public o
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-05-20 8:00 AM EDT | Optimi Health Corp.
Optimi Health gibt Preisfestsetzung für überzeichnetes öffentliches Angebot in Höhe von 15 Mio. US-$ und Nasdaq-Uplisting bekannt
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 20. Mai 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (das "Unternehmen" oder "Optimi"), ein pharmazeutisches Unternehmen im kommerziellen Stadium mit Fokus auf die Herstellung und den Vertrieb fertiger psychedelischer Arzneimittelprodukte, gab heute die Preisfestsetzung seines gezeichneten öffentlichen Angebots (das "Angebot") im Zusammenhang mit dem Uplisting seiner Stammaktien an den Nasdaq Capital Market bek
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-05-20 8:00 AM EDT | Optimi Health Corp.
PreveCeutical Announces Extension of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has extended the closing of its private non-brokered private placement (the "Offering") of units of the Company (each, a "Unit") to raise gross proceeds of $1,000,000 to June 12, 2026 and intend
Biotechnology, Pharmaceuticals, Health
2026-05-19 7:36 PM EDT | PreveCeutical Medical Inc.
NorthPalm Capital Launches as AI-Augmented Investment Company
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm" or the "Company") is pleased to announce the launch of NorthPalm Capital[1], an AI-augmented investment company focused on identifying and supporting high-growth opportunities across technology and digital asset sectors. The launch reflects NorthPalm's evolution into a leaner, high-conviction investment company with a modern approach to sourcing, evaluating, and act
Biotechnology, Healthcare and Hospitals, Health
2026-05-19 8:36 AM EDT | NorthPalm Capital Corp.
UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors
Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies. John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therap
2026-05-19 8:30 AM EDT | UberDoc
Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
Reno, Nevada--(Newsfile Corp. - May 19, 2026) -
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-19 8:30 AM EDT | Conexeu Sciences Inc.
Edison Issues Report on Alkemya Metacore
London, United Kingdom--(Newsfile Corp. - May 19, 2026) - Edison issues report on Alkemya Metacore. The Alkemya Metacore token offers exposure to trade and investment activities in high-technology metals with a particular focus on ultra-pure nickel and its specialised applications. The core asset of c 7m linear metres of 99.99% purity 0.025mm diameter nickel wire has been independently valued at $1.64bn. Not intended for persons in the US and only for qualified investors
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-05-19 7:56 AM EDT | Edison Group
Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, together with its portfolio company CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers, is pleased to announce the opening of a new Hanf.
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-05-19 7:30 AM EDT | Neural Therapeutics Inc.
QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S. Groen (Ret.) to Advisory Board Following Live Platform Demonstration
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announces the appointment of Lieutenant General Michael S. Groen (Ret.) to its Advisory Board. Lt. Gen. Groen is the former Director of the Joint Artificial Intelligence Center (JAIC) at the US Department of Defense. Lt. Gen. Groen reviewed the QAI platform during a live demonstration in Toronto prior to confirming
2026-05-19 7:03 AM EDT | QScreen AI Inc.
Promino Renews José Bautista for New Two-Year Term Following Strong Progress in Company Turnaround
Burlington, Ontario--(Newsfile Corp. - May 19, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company") announces that Major League Baseball All-Star José Bautista has renewed his partnership with the Company for an additional two-year term. Under the renewed agreement, Mr. Bautista will continue to represent both Promino™ NSF Certified for Sport® and Rejuvenate Muscle Health™ while expanding his in
Food / Beverages, Sports, Health
2026-05-19 7:00 AM EDT | Promino Nutritional Sciences, Inc.
WELL Health Announces Approval of Normal Course Issuer Bid
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Notice of Intention to Make a Normal Course Issuer Bid ("NCIB") it filed with the Toronto Stock Exchange ("TSX") has been appr
Technology, Computer Software, Healthcare and Hospitals, Health
2026-05-19 7:00 AM EDT | WELL Health Technologies Corp.
Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities
Montreal, Quebec--(Newsfile Corp. - May 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the expansion of internal capabilities to execute critical stages of its ACCUM®-enabled Antibody Drug Conjugates ("ADC") development pipeline. The Company has strengthened its purification, analytical characterization, conjugation
Biotechnology, Pharmaceuticals, Health
2026-05-19 3:15 AM EDT | Defence Therapeutics Inc.
Microbiome Labs launches EpicDefense on Amazon
Franklinton, North Carolina--(Newsfile Corp. - May 18, 2026) - Microbiome Labs™, a leader in microbiome-based solutions, announces the official launch of EpicDefense™ on Amazon, expanding consumer access to its latest microbiome-focused immune-support formula. EpicDefense is formulated to support the body's natural defenses and promote respiratory com
2026-05-18 10:00 AM EDT | Microbiome Labs
Functional Brands Announces First Quarter 2026 Financial Results
Lake Oswego, Oregon--(Newsfile Corp. - May 18, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Revenue grew to $1.65 million, up 3.5% from $1.59 million in the prior year period, reflecting continued momentum across the Company's brand portfolio. Gross profit
Household / Consumer / Cosmetics, Health
2026-05-18 8:00 AM EDT | Functional Brands Inc.
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis™ technology and sustainable plant-based molecule development, today announced the expansion of its collaboration with Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, broadening the scope of their
Biotechnology, Pharmaceuticals, Health
2026-05-18 7:00 AM EDT | BioHarvest Sciences Inc.